Long-term remission of a Her2/neu positive primary breast cancer under double monoclonal antibody therapy with trastuzumab and bevacizumab

BACKGROUND: The attempt to act on several signalling pathways involved in tumour development simultaneously appears to be more attractive than attacking a single target structure alone. Vascular endothelial growth factor (VEGF) over-expression is frequently observed in human epidermal growth factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Königsberg, Robert, Maierhofer, Julia, Steininger, Tanja, Kienzer, Gabriele, Dittrich, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Versita, Warsaw 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078037/
https://www.ncbi.nlm.nih.gov/pubmed/24991208
http://dx.doi.org/10.2478/raon-2013-0083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078037/
https://www.ncbi.nlm.nih.gov/pubmed/24991208
http://dx.doi.org/10.2478/raon-2013-0083

Ejemplares similares